SCHEMBL6798531

SCHEMBL6798531

Cc1cccc(N(C(N)=O)c2ccc(-c3ccc(CN4CCOCC4)c4onc(N)c34)cc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 12/20 0.59
FLT3 P36888 10/20 0.59
KIT P10721 10/20 0.59
IKBKE Q14164 1/20 0.51
TEK Q02763 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
INSR P06213 2/20 0.37
CHUK O15111 1/20 0.37
MAPK8 P45983 1/20 0.37
CAMKK2 Q96RR4 1/20 0.37
MET P08581 2/20 0.37
ICMT O60725 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
ACVRL1 P37023 1/20 0.35
JAK2 O60674 2/20 0.35
JAK3 P52333 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27636455 0.90 KIT (0.53) KDRFLT3KITIKBKETEK
SCHEMBL27657320 0.90 KDR (0.51) KDRFLT3KITIKBKEINSR
SCHEMBL27657354 0.90 KDR (0.51) KDRFLT3KITIKBKEINSR
SCHEMBL27636397 0.88 IKBKE (0.62) KDRFLT3KITIKBKETEK
SCHEMBL14953303 0.88 KDR (0.49) KDRFLT3KITIKBKETEK
SCHEMBL420989 0.81 KDR (0.78) KDRFLT3KITIKBKETEK
SCHEMBL27636370 0.80 IKBKE (0.67) KDRFLT3KITIKBKETEK
SCHEMBL27636562 0.80 KDR (0.56) KDRFLT3KITIKBKETEK
SCHEMBL423319 0.77 KDR (0.78) KDRFLT3KITIKBKETEK
SCHEMBL423279 0.76 KIT (0.57) KDRFLT3KITIKBKENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040235892-A1 Indazole and benzisoxazole kinase inhibitors ABBOTT LABORATORIES 2004-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235892-A1 Indazole and benzisoxazole kinase inhibitors ABL1, MAP3K19, MAP3K1 KDR 800/4885FLT3 41/4885KIT 238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.